RFK Jr. Proposes Food Additive Regulation Changes

Why it matters locally: Potential changes to federal food additive regulations could influence food manufacturing practices and consumer product availability throughout Mississippi, similar to other states nationwide.

Robert F. Kennedy Jr. outlined a plan aimed at revising the Food and Drug Administration's (FDA) regulation of food additives. The proposal focuses on substances that food companies add to products, which currently operate under a system that he states offers minimal oversight. Kennedy’s plan specifically targets the 'Generally Recognized As Safe' (GRAS) designation. This classification allows manufacturers to introduce new additives without direct FDA approval if experts widely accept their safety. The plan seeks to eliminate manufacturers' ability to designate additives as GRAS without notifying the FDA. Under the proposed changes, companies would need to submit all GRAS determinations to the FDA for review. The FDA would then have 180 days to assess these determinations. If the agency raises safety concerns during this period, it would require the manufacturer to remove the additive from the market immediately. The plan also addresses existing GRAS designations. It would direct the FDA to review all substances currently on the GRAS list that manufacturers added to products without the agency's direct knowledge or approval. Furthermore, the proposal includes a provision to ban specific food dyes and a common titanium dioxide additive. Kennedy stated, "Children’s health outcomes are deteriorating rapidly and we need urgent action to stop the escalating public health crisis." Critics acknowledge the proposal takes a step toward increased regulation but argue it does not go far enough. They point out that the FDA would still rely on companies to conduct their own safety studies for GRAS substances. These critics advocate for the FDA to conduct independent safety reviews. They also suggest that the proposed 180-day review period for new GRAS notifications might not provide sufficient time for thorough evaluation. One critic, who preferred not to be named due to ongoing discussions, stated, "This proposal would still allow companies to greenlight their own ingredients without independent FDA review. We must close that loophole and restore the public’s trust in our food supply."